Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Treatment/Intervention:  sentinel lymph node biopsy
Trial Status:  Active
Results 1-25 of 54 for your search:
Start Over
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P0334, NCT01501487
Sentinel Lymph Node Mapping Post-Injection Site Pain
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SLNPain01, NCT02065232
Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KHNIC-P14-N001, NCT02287675
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14-005510, NCT02451488
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2009-02-017, NCT01149161
Intraoperative Gamma Camera for Breast Cancer Surgery
Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4126, NCT00757302
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: FCW001, NCT00952679
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SERC / IPC 2012-001, NCT01717131
Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Z0011-China, NCT01796444
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 11-002177, NCI-2013-00645, NCT01826864
Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: SENTINAC-01, NCT02249208
Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy
Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BOOG 2013-08, KWF UM 2014-6679, NCT02271828
Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
Phase: Phase III
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1408153, 2014-004005-32, NCT02279108
Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: SENORITA 2013, NCT01804998
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VST-1001-02, 2013-1021, NCT02294565
Axillary Reverse Mapping
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 100
Sponsor: Other
Protocol IDs: UAMS 78076, NCT00572481
Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0266, NCI-2011-01097, NCT00832429
Breast Lymph Node Mapping
Phase: Phase II
Type: Diagnostic
Status: Approved-not yet active
Age: 19 to 100
Sponsor: Other
Protocol IDs: H09-00926, NCT01038908
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: IMSN001, NCT01642511
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: IMSN002, NCT01668914
Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 2013-02-05, NCT01902953
Hand-held Gamma Camera in the SNOLL Procedure
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 19 to 77
Sponsor: Other
Protocol IDs: P120704, NCT02101320
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-219, NCT00264602
Sentinel Node in Ovarian Cancer
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: NL40323.068.12, NCT01734746
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD 05/11-M, NCT00293865
Start Over